![Richard Williams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Williams
Director Técnico/Científico/I+D en CannBioRex Pharmaceuticals Corp. .
Cargos activos de Richard Williams
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CannBioRex Pharmaceuticals Corp.
![]() CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Director Técnico/Científico/I+D | 01/05/2018 | - |
Kennedy Institute of Rheumatology
![]() Kennedy Institute of Rheumatology Pharmaceuticals: MajorHealth Technology Part of University of Oxford, Kennedy Institute of Rheumatology is a research facility that focuses on studying host-microbe crosstalk in health and disease, with a particular emphasis on inflammatory bowel disease, colorectal cancer, and inflammatory arthritis. The Kennedy Institute of Rheumatology is based in Headington, UK. The institute employs advanced microscopy methods and cutting-edge technology to generate a wide variety of data, which is made available to researchers through the Research Informatics team. The facility aims to future-proof excellence for Bioimaging within Oxford, keeping it competitive with international research. | Corporate Officer/Principal | - | - |
Historial de carrera de Richard Williams
Estadísticas
Internacional
Canadá | 2 |
Reino Unido | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
CannBioRex Pharmaceuticals Corp.
![]() CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Health Technology |
Kennedy Institute of Rheumatology
![]() Kennedy Institute of Rheumatology Pharmaceuticals: MajorHealth Technology Part of University of Oxford, Kennedy Institute of Rheumatology is a research facility that focuses on studying host-microbe crosstalk in health and disease, with a particular emphasis on inflammatory bowel disease, colorectal cancer, and inflammatory arthritis. The Kennedy Institute of Rheumatology is based in Headington, UK. The institute employs advanced microscopy methods and cutting-edge technology to generate a wide variety of data, which is made available to researchers through the Research Informatics team. The facility aims to future-proof excellence for Bioimaging within Oxford, keeping it competitive with international research. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Williams
- Experiencia